Combined treatment of pegvisomant and cabergoline in a cat with hypersomatotropism: insulin-like growth factor 1 normalization and control of comorbidities. [PDF]
Miceli DD +5 more
europepmc +1 more source
A novel germline CDH23 variant as a likely cause of an ultra-giant prolactinoma. [PDF]
Albasri E +7 more
europepmc +1 more source
Editorial Expression of Concern: Does Cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study. [PDF]
Hamid AMSA +4 more
europepmc +1 more source
A Woman's Infertility Journey Complicated by Severe Ovarian Hyperstimulation Syndrome - A Case Report. [PDF]
Khetani S, Hutchison J, Lee CM.
europepmc +1 more source
The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response? [PDF]
Komisarz-Calik M +9 more
europepmc +1 more source
Evanescent Hyperemia: An Underrecognized Cutaneous Manifestation of Postural Orthostatic Tachycardia Syndrome. [PDF]
Ilyas MU, Barlas S, Abid M, Hussain M.
europepmc +1 more source
Prolactinoma localization by inferior petrosal sinus sampling: illustrative case. [PDF]
Ahmed AK +8 more
europepmc +1 more source
Dopamine Agonist Therapy Induced Fatal Pneumocephalus in Giant Prolactinoma. [PDF]
M H A +5 more
europepmc +1 more source
Giant Prolactinoma Resistant to High-Dose Cabergoline in a Young Male Lost to Follow-Up. [PDF]
Das A, Rummun MA, Shams A, Salman A.
europepmc +1 more source
Comparative study between calcium gluconate with diosmin, cabergoline, and cabergoline with diosmin in prevention of ovarian hyperstimulation syndrome in high-risk women undergoing intracytoplasmic sperm injection (ICSI) procedures. [PDF]
Abdallah AM +7 more
europepmc +1 more source

